Announced Tue, 31 Mar · 19:29 IST

Inventurus Knowledge Solutions Limited has informed the Exchange regarding a press release dated March 31, 2026, titled "IKS Health Announces Acquihire of ThinkDTM, an AI-led Company-IKS Health expands patient access team with addition of AI and product design experts".

IKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹1331.50
prior close
₹1376.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-2.0-1.7-2.5+0.2+2.2+6.4+9.7+10.8+13.8+7.4+26.0+23.2+35.6
Up moveDown movePending
AI summary

IKS Health has announced the acquihire of ThinkDTM, an AI-native product, strategy, and digital services company, along with its founder Tij Bedi and his team of AI and product design experts. Bedi will join as Executive Vice President and General Manager for Patient Access and Innovation. The newly added team will help scale and transform IKS Health's patient access portfolio, covering scheduling, registration, demographic capture, insurance eligibility verification, and prior authorizations. The move supports IKS Health's focus on agentic AI and revenue optimization across its care enablement platform serving US health systems. No financial terms, deal value, or acquisition price have been disclosed in this announcement.

Likely market impact

This acquihire strengthens IKS Health's AI and product talent base, particularly in patient access and agentic AI, which could support future revenue growth in its core US healthcare market. For shareholders, the deal signals continued strategic investment in AI capabilities, though the absence of disclosed financial terms makes it hard to gauge near-term cost impact.